Monoclonal anti-LH 40nm OD10 5ml

Added to your cart

Monoclonal anti-LH 40nm OD10 5ml

Cart subtotal: £0.00

View cart (0) Checkout

#SKU BA.LH40/X

£91.00

Price excludes shipping costs.
To view our shipping costs click here.

Need to order this product in bulk?

Contact our team of experts to discuss your bulk requirements

Contact our expert team

Product Details

LH is part of the fertility Gold Conjugate family. Human Luteinizing hormone (lutropin) is essential in human reproduction. In the female, LH triggers ovulation and in the male, it is responsible for the production of testosterone. Conjugated to the 40nm gold nanoparticles (BA.LH40) is a monoclonal antibody which recognises human Luteinizing Hormone and its beta-subunit. This conjugate has been designed to work with a monoclonal capture antibody (01042292M), which recognises human luteinizing hormone and its beta-subunit. With a purity of >95%, it has <1% cross-reactivity with FSH, hCG and TSH. The conjugate is suspended in a low molarity buffer 2mM Borax pH9.0 containing 0.095% Sodium Azide as a preservative. This product can be purchased online in 5ml or 100mL volumes at OD10. For larger volumes, please discuss your requirements with our sales team. Customised concentrations of conjugates to an OD other than OD10 are also available by request.
5ml
BA.LH40/X

More information

Attributes

Description

  • Shipping Information
  • If you are based outside of the EU there will be a 5 day lead time added to your order to enable us to comply with the Animal and Plant Health Agency (APHA) export/import policy
  • Specification
  • OD10, Mean Particle Diameter 37 - 43nm, % CV≤ 8.0%
  • Recommended Use
  • Lateral Flow
  • Preservatives
  • 0.095% azide
  • Lead Time
  • 2 weeks
  • Buffer
  • Low molarity Borax buffer
  • Optical Density
  • OD10
  • Particle Size
  • 40nm

Technical Documents

Safety Data Sheet (82.52KB)

Product Information (384.96KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox